CR1 genotype is associated with entorhinal cortex volume in young healthy adults

Neurobiology of Aging

Volumn 32, Issue 11, 2011, Pages 2106.e7-2106.e11

  Bralten, Janita ^a,b   Franke, Barbara ^b   Arias Vásquez, Alejandro ^b   Heister, Angelien ^b   Brunner, Han G ^b   Fernández, Guillén ^a,b   Rijpkema, Mark ^a  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Alzheimer's disease; Complement receptor 1; Imaging genetics; Magnetic resonance imaging (MRI); Medial temporal lobe; Voxel based morphometry

Indexed keywords

ADULT; ALLELE; ALZHEIMER DISEASE; ARTICLE; BRAIN REGION; BRAIN SIZE; CLU GENE; COHORT ANALYSIS; CONTROLLED STUDY; CR1 GENE; ENTORHINAL CORTEX; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; GRAY MATTER; HETEROZYGOSITY; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MARKER GENE; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICAL RESOLUTION; PICALM GENE; PRIORITY JOURNAL; VOXEL BASED MORPHOMETRY;

EID: 80052632430     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2011.05.017     Document Type: Article

References (23)

1. Bertram L., McQueen M.B., Mullin K., Blacker D., Tanzi R.E. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat. Genet 2007, 39:17-23.
2. Biffi A., Anderson C.D., Desikan R.S., Sabuncu M., Cortellini L., Schmansky N., Salat D., Rosand J. Genetic variation and neuroimaging measures in Alzheimer's disease. Arch. Neurol 2010, 67:677-685. Alzheimer's Disease Neuroimaging Initiative (ADNI).
3. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991, 82:239-259.
4. Chételat G., Villemagne V.L., Bourgeat P., Pike K.E., Jones G., Ames D., Ellis K.A., Szoeke C., Martins R.N., O'Keefe G.J., Salvado O., Masters C.L., Rowe C.C. Relationship between atrophy and beta-amyloid deposition in Alzheimer disease. Ann. Neurol 2010, 67:317-324. Australian Imaging Biomarkers and Lifestyle Research Group.
5. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., Pericak-Vance M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993, 261:921-923.
6. Geroldi C., Pihlajamäki M., Laakso M.P., DeCarli C., Beltramello A., Bianchetti A., Soininen H., Trabucchi M., Frisoni G.B. APOE-epsilon4 is associated with less frontal and more medial temporal lobe atrophy in AD. Neurology 1999, 53:1825-1832.
7. Han X., Jovicich J., Salat D., van der Kouwe A., Quinn B., Czanner S., Busa E., Pacheco J., Albert M., Killiany R., Maguire P., Rosas D., Makris N., Dale A., Dickerson B., Fischl B. Reliability of MRI-derived measurements of human cerebral cortical thickness: the effects of field strength, scanner upgrade and manufacturer. Neuroimage 2006, 32:180-194.
8. Hanggi J., Mondadori C.R., Buchmann A., Henke K., Hock C. A CYP46 T/C SNP modulates parahippocampal and hippocampal morphology in young subjects. Neurobiol. Aging 2009, 32:1023-1032.
9. Harold D., Abraham R., Hollingworth P., Sims R., Gerrish A., Hamshere M.L., Pahwa J.S., Moskvina V., Dowzell K., Williams A., Jones N., Thomas C., Stretton A., Morgan A.R., Lovestone S., Powell J., Proitsi P., Lupton M.K., Brayne C., Rubinsztein D.C., Gill M., Lawlor B., Lynch A., Morgan K., Brown K.S., Passmore P.A., Craig D., McGuinness B., Todd S., Holmes C., Mann D., Smith A.D., Love S., Kehoe P.G., Hardy J., Mead S., Fox N., Rossor M., Collinge J., Maier W., Jessen F., Schurmann B., van den Bussche H., Heuser I., Kornhuber J., Wiltfang J., Dichgans M., Frolich L., Hampel H., Hull M., Rujescu D., Goate A.M., Kauwe J.S., Cruchaga C., Nowotny P., Morris J.C., Mayo K., Sleegers K., Bettens K., Engelborghs S., De Deyn P.P., Van Broeckhoven C., Livingston G., Bass N.J., Gurling H., McQuillin A., Gwilliam R., Deloukas P., Al-Chalabi A., Shaw C.E., Tsolaki M., Singleton A.B., Guerreiro R., Muhleisen T.W., Nothen M.M., Moebus S., Jockel K.H., Klopp N., Wichmann H.E., Carrasquillo M.M., Pankratz V.S., Younkin S.G., Holmans P.A., O'Donovan M., Owen M.J., Williams J. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat. Genet 2009, 41:1088-1093.
10. Hyman B.T., Van Hoesen G.W., Damasio A.R., Barnes C.L. Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science 1984, 225:1168-1170.
11. Jovicich J., Czanner S., Han X., Salat D., van der Kouwe A., Quinn B., Pacheco J., Albert M., Killiany R., Blacker D., Maguire P., Rosas D., Makris N., Gollub R., Dale A., Dickerson B.C., Fischl B. MRI-derived measurements of human subcortical, ventricular and intracranial brain volumes: Reliability effects of scan sessions, acquisition sequences, data analyses, scanner upgrade, scanner vendors and field strengths. Neuroimage 2009, 46:177-192.
12. Kendler K.S., Neale M.C. Endophenotype: a conceptual analysis. Mol. Psychiatry 2010, 15:789-797.
13. Kromer Vogt L.J., Hyman B.T., Van Hoesen G.W., Damasio A.R. Pathological alterations in the amygdala in Alzheimer's disease. Neuroscience 1990, 37:377-385.
14. Lambert J.C., Heath S., Even G., Campion D., Sleegers K., Hiltunen M., Combarros O., Zelenika D., Bullido M.J., Tavernier B., Letenneur L., Bettens K., Berr C., Pasquier F., Fiévet N., Barberger-Gateau P., Engelborghs S., De Deyn P., Mateo I., Franck A., Helisalmi S., Porcellini E., Hanon O., de Pancorbo M.M., Lendon C., Dufouil C., Jaillard C., Leveillard T., Alvarez V., Bosco P., Mancuso M., Panza F., Nacmias B., BossÙ P., Piccardi P., Annoni G., Seripa D., Galimberti D., Galimberti D., Licastro F., Soininen H., Ritchie K., Blanché H., Dartigues J.F., Tzourio C., Gut I., Van Broeckhoven C., Alpérovitch A., Lathrop M., Amouyel P. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat. Genet 2009, 41:1094-1099. European Alzheimer's Disease Initiative Investigators.
15. Mori E., Hirono N., Yamashita H., Imamura T., Ikejiri Y., Ikeda M., Kitagaki H., Shimomura T., Yoneda Y. Premorbid brain size as a determinant of reserve capacity against intellectual decline in Alzheimer's disease. Am. J. Psychiatry 1997, 154:18-24.
16. Rogers J., Li R., Mastroeni D., Grover A., Leonard B., Ahern G., Cao P., Kolody H., Vedders L., Kolb W.P., Sabbagh M. Peripheral clearance of amyloid β peptide by complement C3-dependent adherence to erythrocytes. Neurobiol. Aging 2006, 27:1733-1739.
17. Shaw P., Lerch J.P., Pruessner J.C., Taylor K.N., Rose A.B., Greenstein D., Clasen L., Evans A., Rapoport J.L., Giedd J.N. Cortical morphology in children and adolescents with different apolipoprotein E gene polymorphisms: an observational study. Lancet Neurol 2007, 6:494-500.
18. Shen Y., Li R., McGeer E.G., McGeer P.L. Neuronal expression of mRNAs for complement proteins of the classical pathway in Alzheimer brain. Brain Res 1997, 769:391-395.
19. Sleegers K., Lambert J.C., Bertram L., Cruts M., Amouyel P., Van Broeckhoven C. The pursuit of susceptibility genes for Alzheimer's disease: progress and prospects. Trends Genet 2010, 26:84-93.
20. Tardif C.L., Collins D.L., Pike G.B. Regional impact of field strength on voxel-based morphometry results. Hum. Brain Mapp 2010, 31:943-957.
21. Terai K., Walker D.G., McGeer E.G., McGeer P.L. Neurons express proteins of the classical complement pathway in Alzheimer disease. Brain Res 1997, 769:385-390.
22. Wishart H.A., Saykin A.J., McAllister T.W., Rabin L.A., McDonald B.C., Flashman L.A., Roth R.M., Mamourian A.C., Tsongalis G.J., Rhodes C.H. Regional brain atrophy in cognitively intact adults with a single APOE epsilon4 allele. Neurology 2006, 67:1221-1224.
23. Wyss-Coray T., Yan F., Lin A.H., Lambris J.D., Alexander J.J., Quigg R.J., Masliah E. Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:10837-10842.